Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Novel vaccine offers hope in fight against avian flu
The vaccine reduces the level of avian flu virus chickens shed into the environment.
“Our improved vaccine could help prevent the spread of flu amongst vaccinated birds" - Prof. Munir Iqbal.

A novel vaccine for avian influenza that produces a faster and stronger immune response in chickens compared to current vaccines has been developed by The Pirbright Institute.

The vaccine, reported in the journal npj Vaccines, protects chickens against signs of the H9N2 avian flu strain and reduces the level of virus they shed into the environment. Researchers note an antibody response in chickens as early as six days after they had received the vaccination.

Avian flu vaccines are traditionally produced in chicken eggs. But in this study, researchers made the vaccine in laboratory cultures of insect cells – a technique that makes it easier and less expensive to produce. 

The vaccine works by tagging flu virus proteins with a marker that makes it easier for immune cells, known as Antigen Presenting Cells (APCs), to efficiently capture and process the tagged proteins for triggering an immune response. 

The team specifically tagged the influenza virus haemagglutinin protein (HA) and directed it to target CD83, a protein on the chicken APCs, demonstrating for the first time that this can be used as an effective vaccine. 

“By targeting HA to chicken immune cells, we have generated a powerful addition to the armoury of poultry vaccines,” explained Professor Munir Iqbal, head of Pirbright’s avian influenza virus group. “Our improved vaccine could help prevent the spread of flu amongst vaccinated birds, which is essential for protecting poultry welfare, increasing food production, and reducing the risk of avian influenza spreading to humans.”

As the vaccine does not contain any live flu virus, it is also safer. Researchers say that no specialist high containment facilities are needed for its manufacture – a quality that makes it very attractive for large-scale manufacture.

Work is now underway to assess the vaccine’s potential for commercial production and use in the field.  

Become a member or log in to add this story to your CPD history

Cold-water dip to raise funds for Vetlife

News Story 1
 The veterinary mental health charity Vetlife is inviting the veterinary community to join it for a sponsored cold-water dip.

The event will take place at Walpole Bay, Margate, on 17 May during Mental Health Awareness Week. Participants of all abilities can join in the challenge and are advised to bring a towel, a hot drink, a snack, and warm clothes to get changed into afterwards.

Those taking part are being asked to try to raise 100 each to support the work of the charity.

Details about how to take part can be found here

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.